Hims & Hers Health, Inc. (HIMS) fundamentals score
Launched in 2017, Hims & Hers Health, Inc. has built a consumer-first platform transforming the way customers fulfill their health and wellness needs. It believes that the Company has the technical infrastructure, distributed provider network, and access to clinical capabilities to lead the migration of routine office visits to a personalized, digital, accessible format.
Services-Offices & Clinics of Doctors of Medicine · Healthcare · Listed on NYSE
Overall: 4.6 out of 10, Weak long-term fundamentals
- Growth: 5.4/10
- Profitability: 2.9/10
- Financial health: 5.2/10
- Earnings quality: 4.7/10
- Valuation: 5.0/10
Scores are calculated from Hims & Hers Health, Inc.’s SEC filings, using the 12 months through 2026-06. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Healthcare stocks
- Nurix Therapeutics, Inc. (NRIX): 9.0/10
- Caredx, Inc. (CDNA): 8.9/10
- Dexcom, Inc. (DXCM): 8.8/10
- Exelixis Inc. (EXEL): 8.8/10
- Neurocrine Biosciences Inc. (NBIX): 8.7/10
- Progyny, Inc. (PGNY): 8.6/10
- Healthcare Services Group, Inc. (HCSG): 8.5/10
- Insulet Corporation (PODD): 8.5/10